Thursday, January 29, 2026
12:00 pm - 1:00 pm CT/1:00 - 2:00 pm ET
Register
Cost: FREE for SIDP Members! $10 for non-member attendees
Description:
Antimicrobial stewardship (AMS) is essential to high-quality patient care and is required by regulatory agencies such as The Joint Commission (TJC) and Det Norske Veritas (DNV). Many facilities, however, lack access to infectious diseases (ID) expertise—nearly 80% of U.S. counties have no ID physician—making it difficult to implement and sustain effective stewardship programs. Although tele-stewardship models have demonstrated outcomes comparable to traditional “handshake” stewardship, many clinicians are unfamiliar with how to establish, optimize, and sustain these approaches. Education is needed to support pharmacists and stewardship teams in applying best practices for tele-AMS to meet regulatory expectations and improve antimicrobial use.
The goal of the session is to provide physicians, pharmacists, advanced practice providers, nurses, and other members of the healthcare team with the knowledge and skills to effectively implement tele-antimicrobial stewardship activities, with a focus on team-based collaboration.
Target Audience:
ID-specialized physicians, hospital medicine physicians, antimicrobial stewardship pharmacists, and acute care pharmacists, and board-certified infectious diseases pharmacists. Acute care nurses, advanced practice providers, and other disciplines involved in antimicrobial stewardship activities may also benefit from educational content.
Learning Objectives:
- Describe common tele-AMS program models, core components (prospective audit and feedback, formulary restriction) and evidence supporting their clinical and economic benefit
- Summarize regulatory and infrastructure requirements needed for tele-AMS implementation across different facility types
- Recognize barriers to implementing tele-stewardship initiatives and interprofessional collaboration
- Explain the roles of pharmacists, physicians, and nurses in a tele-AMS team
Faculty:
Zahra Kassamali Escobar, PharmD, BCIDP
Clinical Pharmacist and Co-Medical Director
Fred Hutchison Cancer Center
University of Washington Center for Stewardship in Medicine
Seattle, WA
Stephanie Shealy May, PharmD, BCIDP
Infectious Diseases and Antimicrobial Stewardship Pharmacist
Infectious Diseases Telehealth
Intermountain Health
Salt Lake City, UT
Accreditation:
Pharmacist
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0672-0000-26-001-H01-P
CPE credit: 1.0 contact hour (0.1 CEU)
Type of activity: Knowledge
Release date: January 29, 2026
ACPE Activity Fee: SIDP Member: Free / Non-Member: $10
To receive CE credit, participants must view the CE content, complete a post-test, and complete an evaluation. Proof of completion will be submitted to NABP CPE Monitor.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Participants are responsible for verifying credits were transferred successfully to your NABP eProfile account before the ACPE 60-day deadline. After the 60 day deadline, SIDP will no longer be able to report your credit(s) for this activity.
Funding:
This activity is provided by SIDP. No external funding was received for this activity.
Disclosures:
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, SIDP asks all individuals involved in the development and presentation of CE activities to disclose all financial relationships with ineligible companies. All relevant financial relationships have been mitigated prior to the CE activity. The following financial relationships have been disclosed:
- Dr. Escobar and Dr. May have no relevant financial relationships with an ineligible company to disclose.
- Presentation title and objectives were written by the planning committee and enhanced by AI. All enhancements were reviewed by a human.
Disclaimer:
Faculty members are asked to disclose when any unlabeled/investigational use of pharmaceuticals and devices is being discussed. This activity is intended for educational purposes and should not be used as a substitute for care or advice from a professional. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of SIDP.
The planners and faculty of this continuing education activity have made all reasonable efforts to ensure the accuracy of the information presented in accordance with the latest available scientific knowledge at the time of publication. Healthcare professionals should verify all information and data with recommendations of other authorities before treating patients or employing any therapies described in this continuing education activity.
.gif){kind=logo}